Maria Ruiz-Apellaniz
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.
Journal: The Journal of molecular diagnostics : JMD
Published: February 10, 2017
Human genetics: international projects and personalized medicine.
Journal: Drug metabolism and personalized therapy
Published: August 31, 2015
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Journal: Journal of medical genetics
Published: April 22, 2015
Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.
Journal: Journal of the National Cancer Institute
Published: March 14, 2015
Functional and in silico assessment of MAX variants of unknown significance.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: January 23, 2015
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 22, 2015
High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme.
Journal: The pharmacogenomics journal
Published: May 23, 2014
VEGF, VEGFR3, and PDGFRB protein expression is influenced by RAS mutations in medullary thyroid carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association
Published: April 24, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026